BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 23576469)

  • 1. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
    Wagener G; Raffel B; Young AT; Minhaz M; Emond J
    Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers.
    Benko T; Gallinat A; Minor T; Saner FH; Sotiropoulos GC; Paul A; Hoyer DP
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):716-722. PubMed ID: 28441690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.
    Olthoff KM; Kulik L; Samstein B; Kaminski M; Abecassis M; Emond J; Shaked A; Christie JD
    Liver Transpl; 2010 Aug; 16(8):943-9. PubMed ID: 20677285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
    Khandoga A; Iskandarov E; Angele M; Gerbes A; Frey L; Ağayev B; Jauch KW; Werner J; Guba M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):153-8. PubMed ID: 26545081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.
    Martini S; Tandoi F; Terzi di Bergamo L; Strona S; Lavezzo B; Sacco M; Maione F; Gonella F; Strignano P; Dell Olio D; Salizzoni M; Saracco GM; Romagnoli R
    Liver Transpl; 2017 Jul; 23(7):915-924. PubMed ID: 28422425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early allograft dysfunction and liver transplant outcomes: a single center retrospective study.
    Salvalaggio PR; Felga GE; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2449-51. PubMed ID: 23026617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which score system can best predict recipient outcomes after living donor liver transplantation?
    Chung IS; Park M; Ko JS; Gwak MS; Kim GS; Lee SK
    Transplant Proc; 2012 Mar; 44(2):393-5. PubMed ID: 22410025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation.
    Xu X; Ling Q; Wu J; Chen J; Gao F; Feng XN; Zheng SS
    Liver Int; 2007 Aug; 27(6):816-24. PubMed ID: 17617125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.
    Yunhua T; Weiqiang J; Maogen C; Sai Y; Zhiheng Z; Dongping W; Zhiyong G; Xiaoshun H
    J Clin Monit Comput; 2018 Jun; 32(3):471-479. PubMed ID: 28831767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases.
    Duan BW; Lu SC; Wang ML; Liu JN; Chi P; Lai W; Wu JS; Guo QL; Lin DD; Liu Y; Zeng DB; Li CY; Meng QH; Ding HG; Chen XY; Liao HY; Ma LQ; Chen Y; Zhang J; Xiang HP; Duan ZP; Li N
    J Surg Res; 2013 Aug; 183(2):936-43. PubMed ID: 23558257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELD at POD 1 as a predictor of outcome in liver allografts with peak AST >5000 U/l.
    Hoyer DP; Sotiropoulos GC; Saner FH; Treckmann JW; Paul A; Mathé Z
    Transpl Int; 2014 Dec; 27(12):1285-93. PubMed ID: 25082387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.
    Lee DD; Croome KP; Shalev JA; Musto KR; Sharma M; Keaveny AP; Taner CB
    Ann Hepatol; 2016; 15(1):53-60. PubMed ID: 26626641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.